In the News

Share

Connect with us

Stay Informed.

Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
COVID-19: Information for Patients and Caregivers

We're here for you, and continue to provide cancer care to new and current patients. Learn about our response to COVID-19.

What you need to know

1690 News Items found
Ask the Expert
Angela Katrichis speaks with a patient
The Best Ways to Cope with Active Surveillance

Learn how to cope with stress and anxiety you may feel if you are diagnosed with cancer and your doctor recommends active surveillance instead of treatment.
Michael Kharas
RNA Biology, Stem Cells, and Cancer: At Work with MSK’s Michael Kharas

An inside look at the research of MSK's Dr. Michael Kharas, whose work on RNA biology is shedding new light on cancer.
In the Clinic
MSK radiation oncologist Nancy Lee
Avoiding Surgery for HPV Throat Cancer May Be Possible for More Patients

Learn how HPV-related head and neck cancer can be treated with a sharply reduced radiation dose to prevent side effects, sometimes without surgery.
MSK thoracic oncologist Robert Daly, MD, MBA is seen standing in a clinic hallway.
Cancer Care at Home: MSK Advances Lead the Field

Learn how new clinical trials at MSK are helping make cancer care at home a reality.
The 2024 ASCO sign hangs above a long hallway
Important Findings for Treating Rare Solid Tumors Reported at 2024 ASCO Meeting

Researchers from MSK presented promising studies on treating rare solid tumors including mesothelioma and three types of soft-tissue at the annual meeting of the American Society of Clinical Oncology.
A scientist works at a computer screen with the MSK logo
MSK and NIH Scientists Develop AI Tool to Predict How Cancer Patients Will Respond to Immunotherapy

In a proof-of-concept study, researchers at MSK and the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses routine clinical data, such as that from a simple blood test, to predict whether someone’s cancer will respond to immune checkpoint inhibitors, a type of immunotherapy drug that helps immune cells kill cancer cells.
Large letters that say ASCO promoting annual meeting in Chicago.
MSK Researchers Present Advances in Lung Cancer Treatment at 2024 ASCO Meeting

Read about advances in lung cancer treatment presented by MSK scientists at the 2024 ASCO meeting.
Four people who were successfully treated for rectal cancer in a clinical trial at Memorial Sloan Kettering are seen posing outdoors with the trial’s two principal investigators.
Rectal Cancer Disappears After Experimental Use of Immunotherapy

Rectal cancer patients saw their tumors disappear in a clinical trial involving immunotherapy at Memorial Sloan Kettering Cancer Center—without surgery, radiation, or chemotherapy.
Susan Everson, a transgender woman, was treated at MSK for stage 3 colorectal cancer. She says her care team made her feel welcome, in addition to offering her the most advanced therapies. Susan is now cancer free.
Being Seen: Compassionate Cancer Treatment for Transgender People

Learn how MSK cares for transgender cancer patients, treating them with respect and medical expertise. Staff are specially trained to understand their needs.
MSK breast medical oncologist Janice Shen.
If You Find a Lump in Your Breast, Here’s What To Do Next

Learn what to do if you find a lump in your breast.